Kenzo Iizuka
Chief Tech/Sci/R&D Officer bij DELTA-FLY PHARMA, INC.
Vermogen: 472 893 $ op 31-03-2024
Profiel
Kenzo Iizuka is currently the Director, Head-Research & Development at Delta-Fly Pharma, Inc. He previously worked as a Manager-Third Development at Taiho Pharmaceutical Co., Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DELTA-FLY PHARMA, INC.
1.03% | 31-03-2023 | 85 000 ( 1.03% ) | 472 893 $ | 31-03-2024 |
Actieve functies van Kenzo Iizuka
| Bedrijven | Functie | Begin |
|---|---|---|
| DELTA-FLY PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01-06-2017 |
Eerdere bekende functies van Kenzo Iizuka
| Bedrijven | Functie | Einde |
|---|---|---|
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Health Technology |
| Delta-Fly Pharma, Inc. |
